Macro‐creatine kinase: a neglected cause of elevated creatine kinase
Diagnosis of macro‐CK type 1 obviates the need to carry out pointless and expensive investigations seeking a neuromuscular or cardiac pathology, and also, the unwarranted discontinuation of statin therapy.
Abstract
<jats:title>Abstract</jats:title><jats:p>Macro‐creatine kinase (macro‐<jats:styled-content style="fixed-case">CK</jats:styled-content>) is a neglected cause of raised <jats:styled-content style="fixed-case">CK</jats:styled-content>. Over a 10‐year period, we observed five cases. Three patients had macro‐<jats:styled-content style="fixed-case">CK</jats:styled-content> type 1. One patient with fibromyalgia underwent several explorations to find a muscular pathology; another, who had elevated <jats:styled-content style="fixed-case">CK‐MB</jats:styled-content> (muscle–brain fraction) activity, was referred to a cardiologist, and statin therapy was erroneously discontinued in two patients. Two patients had macro‐<jats:styled-content style="fixed-case">CK</jats:styled-content> type 2: a man with a neuroendocrine carcinoma and a woman with rheumatoid arthritis. Diagnosis of type 1 obviates the need to carry out pointless and expensive investigations seeking a neuromuscular or cardiac pathology, and also, the unwarranted discontinuation of statin therapy. Type 2 must prompt investigations for a neoplasm.</jats:p>